MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro

MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro

Abstract HER2-positive (HER2 +) breast cancer patients that do not respond to targeted treatment have a poor prognosis. The effects of targeted treatment on endogenous microRNA (miRNA) expression levels are unclear. We report that responsive HER2 + breast cancer cell lines had a higher number of miR...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lisa Svartdal Normann, Miriam Ragle Aure, Suvi-Katri Leivonen, Mads Haugland Haugen, Vesa Hongisto, Vessela N. Kristensen, Gunhild Mari Mælandsmo, Kristine Kleivi Sahlberg
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/0b40ee361d9441319955d2b6754721b1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/0b40ee361d9441319955d2b6754721b1

Ejemplares similares